We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Register to chat with like-minded investors on our interactive forums.
| Share Name | Share Symbol | Market | Type |
|---|---|---|---|
| Humacyte Inc | NASDAQ:HUMA | NASDAQ | Common Stock |
| Price Change | % Change | Share Price | Shares Traded | Last Trade
|
|
|---|---|---|---|---|---|
| -0.14 | -1.91% | 7.18 | 1,429,674 | 05:00:08 |
| Bid Price | Offer Price | High Price | Low Price | Open Price | |
|---|---|---|---|---|---|
| 5.00 | 8.11 | 7.41 | 6.96 | 7.15 | |
| Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
|---|---|---|---|---|---|
| Biological Pds,ex Diagnstics | -110.78M | -1.0695 | -10.25 | 1.14B |
| Last Trade Time | Trade Type | Trade Size | Trade Price | Currency |
|---|---|---|---|---|
| 00:59:40 | 20 | 7.09 | USD |
| Date | Time | Source | Headline |
|---|---|---|---|
| 12/9/2023 | 01:03 | DJN | Stocks to Watch: Oracle, Acelyrin, Humacyte |
| 31/7/2023 | 18:28 | DJN | Humacyte Shares Rise 8% After Completing Enrollment in Phase 2/3 Trial |
Humacyte (HUMA) Share Charts1 Year Humacyte Chart |
|
1 Month Humacyte Chart |
Intraday Humacyte Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
